Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


ESMO 2022, the world's premier congress in medical oncology!

The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.

This is the ultimate goal of ESMO 2022 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO 2021  

  • 22 792 participants, 143 countries
  • 70 exhibitors
  • 464 invited speakers
  • 172 sessions, 21 tracks
  • 2845 submitted abstracts

How can I participate in ESMO 2022?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress.

Contact the ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

We gratefully acknowledge the valuable contribution of the following organisations in the ESMO Congress 2022 through their presence in the virtual exhibition, organisation of sponsored sessions, or via sponsorship activities (as of May 2022):

  • AbbVie, Inc.
  • Accord Healthcare Limited
  • Agendia
  • Alkermes
  • Almac Group
  • Amgen
  • Amoy Diagnostics Co., Ltd.
  • Aptitude Health
  • Arcus Biosciences
  • Astellas Pharma Europe Ltd
  • AstraZeneca
  • Axiom Healthcare Strategies
  • Bayer
  • Beacon Medicare Limited
  • BeiGene LTD
  • Biocartis
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb
  • Caris Life Sciences
  • CeGaT
  • CellCarta
  • Celltrion Healthcare
  • Clovis Oncology
  • COR2ED
  • Daiichi Sankyo, Inc.
  • Deciphera Pharmaceuticals
  • Eisai Europe Ltd
  • Eli Lilly and Company
  • Exact Sciences
  • Exelixis, Inc.
  • F. Hoffman-La Roche LTD
  • Fulgent Genetics
  • Genmab
  • Gilead Sciences Europe Ltd.
  • GSK
  • Guardant Health
  • Helsinn Healthcare SA
  • Hengrui
  • HTG Molecular
  • Illumina
  • Immunocore
  • Incyte
  • Invitae
  • Ipsen
  • IQVIA Biotech
  • Janssen
  • Kaiku Health
  • Kephren Publishing
  • LeCancer.fr
  • Median Technologies
  • Medscape Oncology
  • Merck KGaA Darmstadt Germany
  • Merck Pfizer Alliance
  • Mirati Therapeutics, Inc.
  • MSD
  • Myriad Genetics
  • NeoGenomics Laboratories
  • Novartis
  • Novocure GmbH
  • ONCOassist
  • OncoDNA
  • Oncompass Medicine
  • Oxford BioDynamics
  • Paige
  • Pear Bio
  • Pfizer Oncology
  • PharmaMar
  • PierianDX
  • Pierre Fabre
  • PPD, part of Thermo Fisher Scientific
  • Precision for Medicine
  • Regeneron
  • Sanofi
  • Seagen International GmbH
  • Servier
  • Springer Healthcare
  • Stemline Therapeutics
  • Syneos Health
  • Taiho Oncology
  • Takeda Oncology
  • Thermo Fisher Scientific
  • Varian, A Siemens Healthineers Company
  • Vela Diagnostics
  • Wisepress Medical Bookshop

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.